Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 271 AL 285

Positive Mental Health Outcomes in Individuals with Dementia: The Essential Role of Cultural Competence

Jha B, Seavy J, Young D, Bonner A.

Online J Issues Nurs. 2015 Jan 31;20(1):5.

Is Mild Cognitive Impairment a Precursor of Alzheimer's Disease? Short Review

Janoutová J, Šerý O, Hosák L, Janout V.

Cent Eur J Public Health. 2015 Dec;23(4):365-7. doi: 10.21101/cejph.a4414.

Novel cerebrotendinous xanthomatosis mutation causes familial early dementia in Colombia

Giraldo-Chica M, Acosta-Baena N, Urbano L, Velilla L, Lopera F, Pineda N.

Biomedica. 2015 Oct-Dec;35(4):563-71. doi: 10.7705/biomedica.v35i4.2690.

Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays

Lewczuk P, Lelental N, Spitzer P, Maler JM, Kornhuber J.

J Alzheimers Dis. 2015;43(1):183-91. doi: 10.3233/JAD-140771.

Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts

Muenchhoff J, Poljak A, Song F, Raftery M, Brodaty H, Duncan M, McEvoy M, Attia J, Schofield PW, Sachdev PS.

J Alzheimers Dis. 2015;43(4):1355-73. doi: 10.3233/JAD-141266.

Memory profiles in pathology or biomarker confirmed Alzheimer disease and frontotemporal dementia

Mansoor Y, Jastrzab L, Dutt S, Miller BL, Seeley WW, Kramer JH.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):135-40. doi: 10.1097/WAD.0000000000000062.

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort

Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, Dallob A, Chappell D, Snyder K, Flynn M, Simon A, Modur V, Potter WZ, Wilcock G, Savage MJ, Smith AD.

J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.

Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index

Hall A, Mattila J, Koikkalainen J, Lötjonen J, Wolz R, Scheltens P, Frisoni G, Tsolaki M, Nobili F, Freund-Levi Y, Minthon L, Frölich L, Hampel H, Visser PJ, Soininen H.

Curr Alzheimer Res. 2015;12(1):69-79. doi: 10.2174/1567205012666141218123829.

Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?

Chen J, Zhang Z, Li S.

Neurosci Bull. 2015 Feb;31(1):128-40. doi: 10.1007/s12264-014-1490-8. Epub 2015 Jan 16.

Dementia in 2014. Towards early diagnosis in Alzheimer disease

Nordberg A.

Nat Rev Neurol. 2015 Feb;11(2):69-70. doi: 10.1038/nrneurol.2014.257. Epub 2015 Jan 27.

Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease

Leuzy A, Carter SF, Chiotis K, Almkvist O, Wall A, Nordberg A.

J Alzheimers Dis. 2015;45(4):1077-88. doi: 10.3233/JAD-142952.

A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease

Olazarán J, Gil-de-Gómez L, Rodríguez-Martín A, Valentí-Soler M, Frades-Payo B, Marín-Muñoz J, Antúnez C, Frank-García A, Acedo-Jiménez C, Morlán-Gracia L, Petidier-Torregrossa R, Guisasola MC, Bermejo-Pareja F, Sánchez-Ferro Á, Pérez-Martínez DA, Manzano-Palomo S, Farquhar R, Rábano A, Calero M.

J Alzheimers Dis. 2015;45(4):1157-73. doi: 10.3233/JAD-142925.

Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies

Lista S, Dubois B, Hampel H.

J Nutr Health Aging. 2015 Feb;19(2):154-63. doi: 10.1007/s12603-014-0515-3.

Neuroinflammation in Alzheimer's disease

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP.

Lancet Neurol. 2015 Apr;14(4):388-405. doi: 10.1016/S1474-4422(15)70016-5.

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease

Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen CH, Karow DS, Brewer JB, Hess CP, Williams J, Sims R, O'Donovan MC, Choi SH, Bis JC, Ikram MA, Gudnason V, DeStefano AL, van der Lee SJ, Psaty BM, van Duijn CM, Launer L, Seshadri S, Pericak-Vance MA, Mayeux R, Haines JL, Farrer LA, Hardy J, Ulstein ID, Aarsland D, Fladby T, White LR, Sando SB, Rongve A, Witoelar A, Djurovic S, Hyman BT, Snaedal J, Steinberg S, Stefansson H, Stefansson K, Schellenberg GD, Andreassen OA, Dale AM; Inflammation working group, IGAP and DemGene Investigators.

Circulation. 2015 Jun 9;131(23):2061-2069. doi: 10.1161/CIRCULATIONAHA.115.015489. Epub 2015 Apr 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias